See reviews below to learn more or submit your own review. Bausch & Lomb has manufactured eye health products and vision care solutions since 1853. The company is a global supplier of contact ...

Bausch + Lomb has recalled lenses used during cataract ... The company recalled the products after receiving an increased number of reports of toxic anterior segment syndrome (TASS), an ...

Bausch + Lomb's Q3 performance showed revenue growth and a shift to net income, driven by new products like Xiidra and Miebo. Despite bankruptcy rumors, major institutional investors like Carl ...

It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products.

Bausch + Lomb Corporation’s BLCO share price has surged by 7.05%, which has investors questioning if this is right time to sell.

The second suit, which alleged claims for patent infringement on the macular degeneration product, concerns two Bausch & Lomb products sold under the PreserVision label. The complaint alleged that ...

Bausch & Lomb is one of the largest vision care companies in the US. Bausch spun off from its former parent company, Bausch Health, in 2022 and it now operates in three segments: vision care ...

Eye health products company Bausch + Lomb is teaming up with Walmart to host eye care clinics at dozens of the retailer’s stores nationwide. “Eye Care for My Care” aims to help educate ...

Founded in 1853, Bausch + Lomb has a portfolio of 400 products spanning eye care, contact lenses, ophthalmic pharmaceuticals, ophthalmic surgical devices, and instruments, as well as over-the ...

Bausch + Lomb is one of the leading contact-lens suppliers ... We sell different types of products and services to both investment professionals and individual investors. These products and ...